News
Are Beta-Blockers Safe for COPD?
A COPD with comorbid CV disease RCT is unlikely, says physician, though benefit of stopping beta-blockers is unclear.
Opinion
The Tyranny of Beta-Blockers
In addition to left ventricular function, there are other factors that are likely to drive variability in patients’ responses to beta-blockers.
News
CPAP Underperforms: The Sequel
Dr. Holley discusses comments on his prior column on CPAP and the lack of data on CV improvement with CPAP use.
Opinion
CPAP Oversells and Underperforms
CPAP doesn’t seem to improve CVD-related outcomes. In some cases, it’s even harmful.
Opinion
Revisiting the role of hydrocortisone, fludrocortisone in septic shock
Two decades after choosing not to treat septic shock with hydrocortisone and fludrocortisone, the author describes why he is reconsidering.
Opinion
When does a bicarb drip make sense?
Intravenous bicarbonate can lead to intracellular acidosis, hypercapnia, hypocalcemia, and a reduction in oxygen delivery.
Opinion
PRISm and nonspecific pattern: New insights in lung testing interpretation
The “restrictive pattern” label is due for retirement.
Opinion
Parsing the split-decision victory for biologics in COPD
It’s tough to keep up with the proliferation of monoclonal antibodies.
News
Antibiotics for acute exacerbation of COPD: It’s still controversial
Who gets an antibiotic and who doesn’t for AECOPD treatment is controversial.
Opinion
Fatigue is a monster for patients with pulmonary disease
Outside of sleep medicine, I see little focus on fatigue among pulmonologists.
News
The challenge of incidentally detected interstitial lung abnormalities
Depending on population characteristics, ILAs occur at a prevalence of up to 10%.
Opinion
The latest on ERS/ATS lung function interpretation guidelines and bronchodilator testing
The 12% and 200-cc criteria suggested in 2005 are being retired.
Opinion
The winding road that leads to optimal temperature management after cardiac arrest
Today’s life-saving intervention proves harmful tomorrow, but withholding it may constitute malpractice a few months down the road.
Opinion
Exercise limitations in COPD – not everyone needs more inhalers
Only one of three major COPD abnormalities responds to inhalers.